ORPEA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.17 EUR | 0.00% |
|
-0.16% | -33.89% |
| Apr. 17 | Emeis: EbitdaR target revised downwards for 2024 | CF |
| Apr. 17 | French care home group Emeis cuts core profit target for 2024 | RE |
| Sales 2023 | 5.2B 5.55B | Sales 2024 * | 5.44B 5.8B | Capitalization | 1.78B 1.9B |
|---|---|---|---|---|---|
| Net income 2023 * | -439M -469M | Net income 2024 * | -202M -216M | EV / Sales 2023 | 0.42 x |
| Net Debt 2023 * | 7.54B 8.05B | Net Debt 2024 * | 6.6B 7.05B | EV / Sales 2024 * | 1.54 x |
| P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-0.01
x | Employees | 76,000 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 95.16% |
More Fundamentals
* Assessed data
More news
Latest transcript on ORPEA
More recommendations
More press releases
More news
| 1 week | -0.16% | ||
| Current month | +10.20% | ||
| 1 month | -0.25% | ||
| 3 months | -19.63% | ||
| 6 months | -99.09% | ||
| Current year | -33.89% |
1 week
10.46
11.34
1 month
9.9714.40
Current year
9.9718.10
1 year
9.973 519.99
3 years
9.97111 100.00
5 years
9.97129 000.00
10 years
9.97129 000.00
| Managers | Title | Age | Since |
|---|---|---|---|
Laurent Guillot
CEO | Chief Executive Officer | 54 | 22-06-30 |
Laurent Lemaire
DFI | Director of Finance/CFO | - | 21-12-07 |
| Chief Tech/Sci/R&D Officer | - | 22-10-09 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 65 | 22-07-27 | |
Laurent Guillot
CEO | Chief Executive Officer | 54 | 22-06-30 |
Mireille Faugère
BRD | Director/Board Member | 66 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.13% | 18 M€ | +2.63% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-17 | 11.17 | 0.00% | 171,228 |
| 24-04-16 | 11.17 | +2.51% | 207,015 |
| 24-04-15 | 10.9 | -0.27% | 242,671 |
| 24-04-12 | 10.93 | -0.38% | 181,289 |
| 24-04-11 | 10.97 | -1.97% | 158,720 |
Real-time Euronext Paris, April 17, 2024 at 11:39 am EDT
More quotes
ORPEA is the European leader in global dependency care. The group operates retirement homes, follow-up care clinics, and psychiatric clinics.
At the end of 2022, ORPEA had a network of 992 facilities (90,860 beds) located in France (358 facilities; 33,462 beds), Benelux/the United Kingdom/Ireland (193 facilities; 10,708 beds), Central Europe (237 facilities; 23,765 beds), Eastern Europe (124 facilities; 12,764 beds), the Iberian Peninsula and Latin America (79 facilities; 10,007 beds) and China (1 facility; 154 beds)
The group has a real estate portfolio of nearly 2.3 million m2 with a value of EUR 6,500 million.
Net sales are distributed geographically as follows: France/Benelux/the United Kingdom/Ireland (59.9%), Central Europe (25.6%), Eastern Europe (9.3%), Iberian Peninsula and Latin America (5.1%) and other (0.1%).
Calendar
2024-09-23
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
4
Last Close Price
11.17
EUR
Average target price
10,975
EUR
Spread / Average Target
+98,136.66%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -33.89% | 1.89B | |
| -18.80% | 1.5B | |
| -5.13% | 1.34B | |
| +11.00% | 1.19B | |
| +11.40% | 680M | |
| -2.73% | 469M | |
| -6.56% | 356M | |
| +196.58% | 346M | |
| -7.10% | 114M | |
| +36.37% | 85.95M |
- Stock Market
- Equities
- ORP Stock
